Our knowledge about premature children, and their physical and mental development as they grow up, is constantly growing. In recent years several studies of…
In February 2009, black abalone was listed as endangered under the Endangered Species Act, and the Act requires critical habitat be designated, to the maximum…
This application provides global-scale biological and ecosystem information on symbiotic zooxanthellae called Symbiodinium which are uni-cellular,…
Insulated in a luxuriously thick winter coat, reindeer are perfectly prepared for the gripping cold of an Arctic winter.But the pelt doesn't just keep the cold…
They say the procedure known as a nipple sparing mastectomy is also a viable surgical option for women who choose to have their breasts removed because of…
In a study scheduled for publication in the December issue of the Archives of Physical Medicine and Rehabilitation, researchers report on the first comparative…
Atorvastatin therapy was found to be ineffective in reducing atherosclerosis progression in children and adolescents with systemic lupus erythematosus (SLE)….
The present invention relates to antibodies that exhibit a high affinity and specificity for the A1/B-domains of CEACAM1.
Commercial Opportunities
CEACAM1 is an adhesion receptor molecule implicated in growth regulation and the development of cancer. It belongs to the family of carcinoembryonic antigens which forms a part of the immunoglobulin superfamily (IgSF). CEACAMs play a central role with respect to cell adhesion, differentiation, activation, proliferation, morphogenesis and apoptosis as well as receptors for various pathogens (e. g. bacteria). CEACAMs are structurally closely related: they feature the function triggering N-domain and a C-domain consisting of A- and B-domains. Due to the structural similarity it is very challenging to obtain antibodies against specific CEACAM1-domains. CEACAM1 has been detected at elevated levels in the surrounding tissue of tumors and the tumors themselves. It appears that CEACAM1 is a suitable biomarker for the diagnosis and staging of tumors.
The present invention relates to antibodies that exhibit a high affinity and mono-specificity for the A1/B-domains of human CEACAM1. Thus, they are suitable to detect the membrane anchored, the cleaved soluble CEACAM1 and most of its derivatives and may be used in various in-vitro techniques in cancer research, e.g. ELISA, WB, IHC, fluorescence microscopy and flow cytometry.
The present invention relates to antibodies that exhibit a high affinity and specificity for the A1/B-domains of CEACAM1.
Commercial Opportunities…
Siemens has launched a new campaign with the motto “Turn your city pink! Raise awareness for breast cancer.”. The company is encouraging people around the…
The new Siemens software solution is now controlling the quality of measurement of over 60 of the refinery company's analyzers, and recording data quality…
The signals to make lipid after a meal come from hormones – most notably insulin – and the direct effect of nutrients on the liver. In a recent issue of Cell…
However, when their genomes were later sequenced, researchers were surprised to learn that the DNA sequences of human and chimpanzee genes are nearly…
The team found that three of these variants were associated with impaired sensitivity to the common blood thinner clopidogrel, and a fourth that affects a…
Simple stirring can influence light, according to a report presented in the journal Angewandte Chemie by Kunihiko Okano and co-workers. Dye molecules locked in…
When corn stover is processed to make cellulosic ethanol, everything is ground down and blended together. But a research team found that three distinct parts…
Feedback
